Prognostic factors in mortality and morbidity in patients with differentiated thyroid cancer

Ear, Nose and Throat Journal

Volumn 81, Issue 12, 2002, Pages 856-863

  Witt, Robert L ^a,b   McNamara, Ann Marie ^a  

^a CHRISTIANA CARE HEALTH SYSTEM   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE; THYROGLOBULIN;

ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; CANCER REGISTRY; HUMAN; HYPOCALCEMIA; MORBIDITY; PROGNOSIS; RECURRENT LARYNGEAL NERVE PALSY; RISK FACTOR; SCORING SYSTEM; SEX DIFFERENCE; SUBTOTAL THYROIDECTOMY; THYROID CANCER; THYROIDECTOMY; TUMOR VOLUME;

EID: 0036906378     PISSN: 01455613     EISSN: None     Source Type: Journal    
DOI: 10.1177/014556130208101217     Document Type: Article

References (42)

1. Cady B. Surgery of thyroid cancer. World J Surg 1981;5:3-14.
2. Tollefsen HR, Decosse JJ, Hurter RVP. Papillary carcinoma of the thyroid. A clinical and pathological study of 70 fatal cases. Cancer 1964;17:1035-44.
3. Glass GV. Primary, secondary, and meta-analysis of research. Educ Res 1976;5:3-8.
4. Rosenfeld RM. How to systematically review the medical literature. Otolaryngol Head Neck Surg 1996;115:53-63.
5. Haughey BH, Gates GA, Arfken CL, Harvey J. Meta-analysis of second malignant tumors in head and neck cancer: The case for an endoscopic screening protocol. Ann Otol Rhinol Laryngol 1992;101:105-12.
6. Farrar WB, Cooperman M, James AG. Surgical management of papillary and follicular carcinoma of the thyroid. Ann Surg 1980;192:701-4.
7. Mazzaferri EL, Young RL. Papillary thyroid carcinoma: A 10-year follow-up report of the impact of therapy in 576 patients. Am J Med 1981;70:511-8.
8. Christensen SB, Ljungberg O, Tibblin S. Surgical treatment of thyroid carcinoma in a defined population: 1960 to 1977. Evaluation of the results after a conservative surgical approach. Am J Surg 1983;146:349-54.
9. Cohn KH, Backdahl M, Forsslund O, et al. Biologic considerations and operative strategy in papillary thyroid carcinoma: Arguments against the routine performance of total thyroidectomy. Surgery 1984;96:957-71.
10. Hay ID, Grant CS, Taylor WF, McConahey WM. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: A retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 1987;102:1088-95.
11. Andry G, Chantrain G, van Glabbeke M, Dor P. Papillary and follicular thyroid carcinoma. Individualization of the treatment according to the prognosis of the disease. Eur J Cancer Clin Oncol 1988;24:1641-6.
12. Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 1988;104:947-53.
13. Arnold RE, Edge BK. A descriptive experience of total thyroidectomy as the initial operation for differentiated carcinoma of the thyroid. Am J Surg 1989;158:396-8.
14. Sethi VK. Differentiated thyroid cancer: Outcome of treatment in 80 cases. Ann Acad Med Singapore 1990;19:435-8.
15. Noguchi M. Earashi M. Kitagawa H, et al. Papillary thyroid cancer and its surgical management. J Surg Oncol 1992;49:140-6.
16. Ley PB, Roberts JW, Symmonds RE Jr., et al. Safety and efficacy of total thyroidectomy for differentiated thyroid carcinoma: A 20-year review. Am Surg 1993;59:110-4.
17. Balan KK, Raouf AH, Critchley M. Outcome of 249 patients attending a nuclear medicine department with well differentiated thyroid cancer: A 23 year review. Br J Radiol 1994:67:283-91.
18. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994;97:418-28.
19. Lin JD, Jeng LB, Chao TC, et al. Surgical treatment of papillary and follicular thyroid carcinoma. Int Surg 1996;81:61-6.
20. Segal K, Raveh E, Lubin E, et al. Well-differentiated thyroid carcinoma. Am J Otolaryngol 1996;17:401-6.
21. Yasumoto K, Miyagi C, Nakashima T, et al. Papillary and follicular thyroid carcinoma: The treatment results of 357 patients at National Kyushu Cancer Centre of Japan. J Laryngol Otol 1996;110:657-62.
22. Shaha AR, Shah JP, Loree TR. Low-risk differentiated thyroid cancer: The need for selective treatment. Ann Surg Oncol 1997;4:328-33.
23. Tsang RW, Brieriey JD, Simpson WJ, et al. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma. Cancer 1998;82:375-88.
24. Yamashita H, Noguchi S, Yamashita H, et al. Changing trends and prognoses for patients with papillary thyroid cancer. Arch Surg 1998;133:1058-65.
25. Brierley JD, Panzarella T, Tsang RW, et al. A comparison of different staging systems predictability of patient outcome. Thyroid carcinoma as an example. Cancer 1997;79:2414-23.
26. Clark RL, Ibanez ML, White EC. What constitutes an adequate operation for carcinoma of the thyroid? Arch Surg 1966;92:23-6.
27. Kaplan EL. Endocrine surgery. J Am Coll Surg 1999;188:118-26.
28. Starnes HF, Brooks DC, Pinkus GS, Brooks JR. Surgery for thyroid carcinoma. Cancer 1985;55:1376-81.
29. Tollefsen HR, Shah JP, Huvos AG. Papillary carcinoma of the thyroid. Recurrence in the thyroid gland after initial surgical treatment. Am J Surg 1972;124:468-72.
30. Beahrs OH. Surgical treatment for thyroid cancer. Br J Surg 1984; 71:976-9.
31. Cady B. Presidential address: Beyond risk groups - A new look at differentiated thyroid cancer. Surgery 1998;124:947-57.
32. Balerwaltes WH, Rahbani R, Dmuchowski C, et al. An analysis of "ablation of thyroid remnants" with I-131 in 511 patients from 1947-1984: Experience at University of Michigan. J Nucl Med 1984;25:1287-93.
33. Byar DP, Green SB, Dor P, et al. A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group. Eur J Cancer 1979;15:1033-41.
34. Kukkonen ST, Hoapiainen RK, Franssila KO, Sivula H. Papillary thyroid carcinoma: The new, age-related TNM classification system in a retrospective analysis of 199 patients. World J Surg 1990;14:837-41; discussion 841-2.
35. Hay ID, Bergstralh EJ, Goellner JR, et al. Predicting outcome in papillary thyroid carcinoma: Development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993; 114:1050-7; discussion 1057-8.
36. DeGroot LJ, Kaplan EL, Straus FH, Shukla MS. Does the method of management of papillary thyroid carcinoma make a difference in outcome? World J Surg 1994;18:123-30.
37. Shaha AR, Loree TR, Shah JP. Intermediate-risk group for differentiated carcinoma of thyroid. Surgery 1994;116:1036-40; discussion 1040-1.
38. Noguchi S, Murakami N, Kawamoto H. Classification of papillary cancer of the thyroid based on prognosis. World J Surg 1994; 18:552-7; discussion 558.
39. Akslen LA. Prognostic importance of histologic grading in papillary thyroid carcinoma. Cancer 1993;72:2680-5.
40. Hay ID, Grant CS, Bergstralh EJ, et al. Unilateral total lobectomy: Is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma? Surgery 1998;124:958-64; discussion 964-6.
41. Mazzaferri EL. An overview of the management of papillary and follicular thyroid carcinoma. Thyroid 1999;9:421-7.
42. Sanders LE, Cady B. Differentiated thyroid cancer: Reexamination of risk groups and outcome of treatment. Arch Surg 1998;133:419-25.